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Albumin Tagliacozzo is a fast-moving genetic variant of human serum albumin found in 19 unrelated fami- 
lies. The protein was isolated from the serum of a heterozygous healthy subject. Analysis of CNBr fragments 
by isoelectric focusing allowed us to localize the mutation to CNBr fragment IV (residues 299-329). This 
fragment was isolated on a preparative scale and subjected to tryptic digestion. Sequential analysis of the 
abnormal tryptic peptide, purified by RP-HPLC, revealed the variant was caused by 313 Lys-+Asn substitu- 
tion, probably due to a point mutation in the structural gene. The lack of a lysine residue accounts for the 
electrophoretic behavior of albumin Tagliacozzo. 
(Human serum) Albumin Genetic variant Isoelectric focusing HPLC Amino acid sequence 
1. INTRODUCTION 
Over 20 genetic variants of human serum 
albumin have been identified, based on their dif- 
fering electrophoretic mobilities [l] which can be 
either faster or slower than that of normal 
albumin. So far, the molecular abnormalities 
responsible for nine of these variants have been 
elucidated [2-lo]. Here, we have investigated the 
molecular defect of albumin Tagliacozzo, a fast- 
running variant which has recently been found in 
19 unrelated families in Abruzzo (Italy). As 
reported by Zepponi et al. [ll] this variant 
possesses the same electrophoretic mobility as 
albumin Reading [ 121 when compared on cellulose 
acetate electrophoresis at pH 8.6. 
The results reported here show that albumin 
Tagliacozzo arises from 313 Lys-Asn 
substitution. 
2. MATERIALS AND METHODS 
2.1. Albumin purification 
Serum was collected from a young healthy male 
heterozygous for the variant, which accounted for 
50% of the total albumin, and processed as 
described by Winter et al. [2]. Homogeneity of the 
protein was checked by gradient gel electrophoresis 
1131. 
2.2. Screening of CNBr fragments 
Whole reduced fast and normal albumins were 
carboxymethylated [14] and cleaved with CNBr 
t151. CNBr fragments were analyzed by 
polyacrylamide gel isoelectric focusing performed 
in the presence of 8 M urea in the pH intervals 
2.5-8 and 2.5-4 as described [8]. 
2.3. Isolation of CNBr IV from albumin 
Tagliacozzo 
The unreduced protein was carboxyamido- 
methylated at Cys 34, cleaved with CNBr and the 
four fragments, named A-D according to 
McMenamy et al. [16], were separated by 
Sephadex G-100 gel filtration followed by ion- 
exchange chromatography [ 171. Fragment A 
(residues 299-585) is composed of four sub- 
fragments (CNBr IV, V, VI, VII) held together by 
S-S bonds. CNBr IV was further purified, after 
reduction of disulfide bridges, by ion-exchange 
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chromatography on a CM-cellulose column [16]. 
2.4. HPLC separation of CNBr IV tryptic 
peptides 
About 75 nmol of CNBr IV fragment were sub- 
mitted to tryptic digestion according to Swenson et 
al. [ 141. The separation of tryptic peptides was per- 
formed at room temperature by RP-HPLC on a 
Waters Associated liquid chromatograph [6]. 
2.5. Structural studies 
N-terminal amino acids were identified as dansyl 
derivatives [18]. Amino acid analyses were carried 
out by ion-exchange chromatography with post- 
column ninhydrin derivatization according to 
Moore [ 191 on a Kontron Cromakon 500 
automatic analyzer. Automated sequence analysis 
of the modified peptide was performed in a 
Beckman 890 M spinning cup liquid phase se- 
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Fig. 1. Resolution of alkylated CNBr fragments of 
albumin Tagliacozzo (lane 1) and normal albumin (lane 
2) in the pH interval 2.5-8. CNBr fragments were 
originally identified by focusing under the same 
conditions each peptide purified by HPLC [25] and are 
numbered according to their order in the known 
sequence of human serum albumin [2]. Fragment CNBr 
II has not been identified, probably owing to its high 
solubility and low dye affinity. Overloading of the gel 
was necessary in order to detect smaller peptides. The 
Fig.2. CM-cellulose ion-exchange chromatography of 
reduced fragment A from albumin Tagliacozzo. 
Peptides were eluted with a three-solution gradient: 
0.033 M HsPOJHzP04 (1000 ml) against 0.01 M 
HsP04/H2POd, 0.10 M NaCl (1000 ml) against 0.10 M 
H3POJHzP04, 0.3 M NaCl (1000 ml), pH 2.7, 
according to McMenamy et al. [16]. The identity of the 
arrow indicates the abnormal fragment. peptides was confirmed by amino acid analysis. 
quenator using the fast-protein Quadrol program 
with precycled polybrene. 
The PTH-amino acid derivatives were identified 
by RP-HPLC on a Beckman Ultrasphere ODS col- 
umn according to Pucci et al. [20]. 
3. RESULTS AND DISCUSSION 
Fast variant and normal albumins were assayed 
for homogeneity by gradient gel electrophoresis, 
N-terminal analysis and amino acid composition. 
The two proteins have an identical molecular mass, 
66.5 kDa, and the same N-terminal residue, Asp, 
while comparative amino acid analyses failed to 
show any significative difference. 
To localize the molecular abnormality to a 
specific region of the polypeptide chain, CNBr 
digests of the reduced and carboxymethylated 
albumins were compared by analytical gel isoelec- 
tric focusing in the pH interval 2.5-8. As shown in 
fig.1 all the CNBr fragments bar one behave iden- 
tically: the band corresponding to CNBr IV from 
the variant focuses at a pH lower than the normal, 
in the proximity of CNBr VII. This finding sug- 
gests that the substitution site of the abnormal 
albumin is located between residues 299 and 329. 
The pZ of the modified fragment, measured in the 
pH interval 2.5-4, differs from that of the normal 
one by about 0.25 pH units, thus suggesting, ac- 
cording to Ui [2 11, that a basic residue, a Lys, since 
CNBr IV contains no Arg or His, is substituted by 
a neutral residue. 
0.6 CNBrV CNBrVl 
CN Br IV 
o 0.4 
2 CN BrVll 
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Table 1 Table 2 
Amino acid composition of the abnormal CNBr 
fragments from albumin Tagliacozzo 
Amino acid composition and N-terminal residues of 
tryptic fragments of CNBr IV from variant Tagliacozzoa 
Fragment A CNBr IV 
Taglia- Normalb Taglia- Normalb 
cozzoa cozzoa 
LYS 29.9 31 2.0 3 
His 6.1 6 _ - 
Arg 10.2 10 - - 
CysC 15.7 16 0.9 1 
Asp 24.2 23 6.1 5 
Thrd 15.9 16 - - 
Serd 11.8 12 1.9 2 
Glu 39.2 39 2.1 2 
Pro 14.2 14 2.1 2 
ClY 6.1 6 1.1 1 
Ala 27.8 28 5.0 5 
Val’ 26.2 26 3.0 3 
Met’ 2.6 3 0.8 1 
Ile’ 3.0 3 _ _ 
Leu 30.3 30 3.1 3 
Tyr 9.7 10 0.9 1 
Phe 14.1 14 2.0 2 
Trp n.d. - n.d. - 
a Compositions are given in residues/mol. The values 
are the means of three independent determinations 
b From sequence [22] 
’ Determined as S-carboxymethylcysteine 
d Corrected for destruction during acid hydrolysis 
e Corrected for slow release during acid hydrolysis 
’ Present as homoserine 
HPLC peaks (from fig.3) 
LYS 
CM-Cys 
Asp 
Ser 
Glu 
Pro 
ClY 
Ala 
Val 
Leu 
Tyr 
Phe 
Homoserine 
N-terminal 
Position in 
1 
0.99 
1.05 
1.06 
2.02 
0.88 
Asx 
2’ 
1.03 
1.05 
1.02 
1.04 
1.01 
0.85 
Asx 
the sequenceb 318-323 324-329 324-329 299-317 
a Values are determined based on the calculated average 
of nmol/residue 
b According to Dugaiczyk et al. [22] 
’ The presence of two peptides with the same amino acid 
compositions is probably due to the homoserine- 
homoserine lactone quilibrium 
n.d., not determined 
To achieve the purification of CNBr IV from 
albumin Tagliacozzo on a preparative scale, frag- 
ment A was isolated from fragments B-D as 
reported in section 2. As expected, comparative 
amino acid analyses of the purified fragments 
allowed us to conclude that only fragment A is 
modified in the abnormal protein: its composition, 
reported in table 1, shows the presence of an addi- 
tional Asp residue and the lack of a Lys residue. 
The modified fragment was then treated with 
trypsin and the digest was resolved by RP-HPLC 
(fig.3). Each peptide was characterized by amino 
acid and N-terminal analyses (table 2). Peak 4 
shows an abnormal amino acid composition cor- 
responding to the sequence 299-317 with the lack 
of the Lys 313 and the presence of an additional 
Asp residue. Sequential analysis of the abnormal 
peptide gives the following results: Pro-Ala-Asp- 
Leu-Pro-Ser-Leu-Ala-Ala-Asp-Phe-Val-Glu-Ser- 
Asn-Asp-Val-Cys-Lys thus demonstrating that 
albumin Tagliacozzo is due to a Lys-Asn 
replacement in position 313 of the sequence. 
Fragment A was then reduced, carboxy- 
amidomethylated and its components were 
separated by ion-exchange chromatography 
(fig.2). CNBr fragments V, VI and VII have the 
same amino acid composition as the normal ones 
while CNBr IV showed the same difference 
detected in the whole fragment A (table 1). 
This lack of one positive charge is consistent 
with the higher anodic mobility of the native pro- 
tein at pH 8.6 as well as with the observed isoelec- 
tric point of CNBr fragment IV. 
The amino acid replacement found in albumin 
Tagliacozzo can be accounted for by a single base 
substitution in the structural gene: codon 313, 
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Fig.3. Reverse-phase high-performance liquid chromatography of the tryptic digest of CNBr IV from albumin 
Tagliacozzo. A 200~1 portion (15 nmol) of the tryptic digest was applied to an Aquapore RP-300 column (2.5 cm x 
7 mm i.d.) obtained from Brownlee Labs equilibrated in 0.05% aqueous TFA (solvent A). Peptides were eluted with 
a 60 min linear gradient from equilibration buffer to 50% CH$N in 0.05% TFA (solvent B). The flow rate was 
2 ml/min. Peptides were detected by their absorbance at 220 nm. The numbers above the peaks refer to the elution 
position. Each peak was submitted to amino acid and N-terminal analysis (table 2). 
AAG in normal albumin [22], is probably changed 
in AAC or AAT both encoding for Asn. This kind 
of replacement, determined by a transversion, a 
purine being substituted by a pyrimidine, is one of 
the most frequently observed changes in 
hemoglobin variants, but Tagliacozzo is the first 
case among abnormal albumins. 
Albumin Tagliacozzo has been reported to 
possess the same electrophoretic mobility first 
described by Tarnoky for albumin Reading [12], 
which was then found in several other variants 
with a wide geographical distribution: albumins 
New Guinea and Westcott, as reported by 
Weitkamp et al. [23], and albumin Cuneo, which 
has been found by Vacca et al. [24] in a family 
group in Piemonte. 
Unfortunately, as the original Reading sample is 
still unavailable (Tarnoky, A.L., personal com- 
munication), it is impossible at present to state its 
structural relationship with albumin Tagliacozzo. 
The other sera are difficult to obtain and we pro- 
cessed only a small amount of albumin Cuneo in 
order to compare it with Tagliacozzo: their CNBr 
fragment patterns, analyzed by gel isoelectric 
focusing as described, are identical, thus sug- 
gesting that they arise from the same mutation. 
In fact, as observed among other variant pro- 
teins, the same amino acid replacements may occur 
on multiple occasions: recently Putnam et al. [9] 
demonstrated that albumin Naskapi, found in the 
Naskapi Indians of Quebec, and albumin Mersin, 
found in Eti Turks of South Eastern Turkey, arise 
367 
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from an identical amino acid change. [91 
Thus it may be that some of these variants with 
the same electrophoretic mobility occurring in peo- 
ple of diverse origins possess identical structural 
properties. 
WI 
1111 
ACKNOWLEDGEMENTS 
This work was supported by grants from the 
Minister0 della Pubblica Istruzione (Rome, Italy). 
The authors wish to thank Dott. E. Zepponi and 
Dott. G. Vacca for gently supplying the sera and 
Dott. K. Dyne for critically reading the 
manuscript. 
REFERENCES 
111 
121 
[31 
141 
151 
161 
[71 
PI 
Weitkamp, L.R., Salzano, F.M., Neel, J.V., 
Porta, F., Geerdink, R.A. and Tarnoky, A.L. 
(1983) Ann. Hum. Genet. 36, 381-392. 
Winter, W.P., Weitkamp, L.R. and Rucknagel, 
D.L. (1972) Biochemistry 11, 889-896. 
Brennan, SO. and Carrell, R.W. (1979) Nature 
274, 908-909. 
Franklin, S.G., Wolf, S.I., Zweidler, A. and 
Blumberg, B.S. (1980) Proc. Natl. Acad. Sci. USA 
77, 2505-2509. 
Abdo, Y., Rousseaux, J. and Dautrevaux, M. 
(1981) FEBS Lett. 131, 286-288. 
Iadarola, P., Minchiotti, L. and Galliano, M. 
(1985) FEBS Lett. 180, 85-88. 
Brennan, S.O. (1985) Biochim. Biophys. Acta 830, 
320-324. 
Galliano, M., Minchiotti, L., Iadarola, P., 
Zapponi, M.C., Ferri, G. and Castellani, A.A. 
(1986) J. Biol. Chem. 261, 4283-4287. 
WI 
u31 
u41 
[I51 
1161 
P71 
[181 
[I91 
PO1 
WI 
P21 
v31 
[241 
[251 
Takahashi, N., Takahashi, Y., Ishioka, N., 
Blumberg, B.S. and Putnam, F.W. (1986) J. 
Chromatogr. 359, 181-191. 
Hutchinson, D.W. and Matejtschuk, P. (1985) 
FEBS Lett. 193, 211-212. 
Zepponi, E., Bruccoleri, F., Balucanti, F., Mei, 
M.T. and Calabrese, M. (1986) J. Lab. Med. 13, 
99-104. 
Tarnoky, A.L. and Lestas, N. (1964) Clin. Chim. 
Acta 9, 551-558. 
Margolis, J. and Wrighley, C.W. (1975) J. 
Chromatogr. 106, 204-209. 
Swenson, R.P., Williams, C.H. jr, Massey, V., 
Ronchi, S., Minchiotti, L., Galliano, M. and Curti, 
B. (1982) J. Biol. Chem. 257, 8817-8823. 
Gross, E. (1967) Methods Enzymol. 11, 238-255. 
McMenamy, R.H., Dintzis, H.M. and Watson, 
F.J. (1971) J. Biol. Chem. 246, 4744-4750. 
Lapresle, C. and Doyen, N. (1975) Biochem. J. 
151, 637-643. 
Gray, W.R. (1972) Methods Enzymol. 25, 
333-344. 
Moore, S. (1968) J. Biol. Chem. 243, 6281-6283. 
Pucci, P., Sannia, G. and Marino, G. (1983) J. 
Chromatogr. 270, 371-377. 
Ui, N. (1973) Ann. NY Acad. Sci. 209, 198. 
Dugaiczyk, A., Law, A. and Dennison, O.E. (1982) 
Proc. Natl. Acad. Sci. USA 79, 71-75. 
Weitkamp, L.R., McDermid, E.M., Neel, J.V., 
Fine, J.M., Petrini, C., Bonazzi, L., Ortali, V., 
Porta, F., Tanis, R., Harris, D.J., Peters, T., 
Ruffini, G. and Johnston, E. (1973) Ann. Hum. 
Genet. 37, 219-226. 
Vacca, G., Trovati, C., Moris, A., Giuliani, A., 
Porta, F. and Tarnoky, A.L. (1974) LAB 1, 
177-180. 
Iadarola, P., Ferri, G., Galliano, M., Minchiotti, 
L. and Zapponi, M.C. (1984) J. Chromatogr. 298, 
336-344. 
368 
